Who founded Kythera Labs?

Kythera Labs was founded by Matt Ryan in 2023.

How much funding has Kythera Labs raised?

Kythera Labs has disclosed $20.9M raised across 2 rounds.

Where is Kythera Labs headquartered?

Kythera Labs is headquartered in Franklin, US.

Kythera Labs

Franklin, US · Founded 2023 · Delaware corporation · 37 employees on LinkedIn

Kythera Labs builds data technology and analytics products for the healthcare and life sciences industries, focused on processing and analyzing large-scale healthcare and real-world data. Its platform supports market analysis, operational decision-making, and BioPharma research for healthcare organizations.

AI & Machine Learning Data & Infrastructure Digital Health Healthtech

Founders & leadership

Kythera Labs was founded in 2023 by Matt Ryan.

Matt RyaninChief Technology Officer

Rob GrantChief Commercial Officer

Glynn DennisinChief Science Officer

Russ SacksinEVP, Innovation and Data Science

Jeremy EllisinEVP, Business Development

Austin PooleNamed on SEC filing

Jay GalbreathNamed on SEC filing

Ryan LeurckinChief Analytics Officer

Jeff McDonaldinChief Executive Officer

Reported raises · per SEC filings

Form D private placements

$20.9M disclosed across 2 rounds · 2023–2024

▶$9.2MraisedMay 2024 · 6 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Rob DraughonDirector
Jeff McDonaldExecutive Officer, Director
Jay GalbreathExecutive Officer
Austin PooleDirector
Jeff KleinDirector
Ryan LeurckExecutive Officer, Director

Offering amount: $9.2M
Amount sold: $9.2M
First sale: May 2024
Incorporated: Corporation, Delaware, 2023
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$11.7MraisedMay 2023 · 3 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Austin PooleDirector, Promoter
Jay GalbreathExecutive Officer, Promoter
Ryan LeurckExecutive Officer, Director, Promoter
Jeff McDonaldExecutive Officer, Director, Promoter

Offering amount: $13.5M
Amount sold: $11.7M
Minimum investment: $25K
First sale: May 2023
Incorporated: Corporation, Delaware, 2023
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 8

by search overlap

RayThera8 shared keywordsRayThera develops small molecule therapies targeting unmet needs in immunology. The company focuses on drug discovery in the biotechnology and immunology space.

IQVIA7 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.

AltaThera Pharmaceuticals7 shared keywordsAltaThera Pharmaceuticals develops hospital-use intravenous drug therapies for treating cardiovascular conditions such as atrial fibrillation, atrial flutter, and ventricular arrhythmias in adult and pediatric patients. Its intravenous approach to antiarrhythmic initiation aims to enable faster therapeutic assessment and more precise dosing for physicians in hospital settings.

Kymera Therapeutics6 shared keywordsKymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins. The company focuses on advancing small molecule therapies designed to address critical health problems across multiple disease areas.

Kite Pharma6 shared keywordsKite Pharma develops CAR T-cell therapies for cancer patients, engineering the immune system's cells to target and attack cancer. Each therapy is individualized per patient through a multi-step manufacturing process.

Definitive Healthcare5 shared keywordsDefinitive Healthcare provides a healthcare commercial intelligence platform with all-payor claims data, reference data, and analytics on hospitals, physicians, payors, procedures, diagnoses, and prescriptions. It serves life sciences companies, healthcare providers, and healthcare-adjacent businesses for market analysis, targeting, and sales and marketing efforts, with an AI-powered intelligence product announced for Winter 2026.

Datavant5 shared keywordsDatavant operates a health data collaboration platform and data network that connects, protects, and activates patient-level data across the U.S. healthcare ecosystem. It serves healthcare organizations including hospitals, health systems, payers, and real-world data partners with products for release of information, data linkage, health data retrieval, privacy, and risk adjustment coding.

KayoThera5 shared keywordsKayo Therapeutics is a biotechnology company developing therapeutics, with a scientific and clinical focus that includes areas such as metabolic disease and oncology. The company is led by an experienced management team supported by scientific and clinical advisory boards.

Companies competing with Kythera Labs for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Kythera Labs do?: Kythera Labs builds data technology and analytics products for the healthcare and life sciences industries, focused on processing and analyzing large-scale healthcare and real-world data. Its platform supports market analysis, operational decision-making, and BioPharma research for healthcare organizations.
Who founded Kythera Labs?: Kythera Labs was founded by Matt Ryan in 2023.
How much funding has Kythera Labs raised?: Kythera Labs has disclosed $20.9M raised across 2 rounds.
Where is Kythera Labs headquartered?: Kythera Labs is headquartered in Franklin, US.